{
  "id": "cluster_4_doc1",
  "content": "The Silverpine Regional Health Network implemented Policy RX-45B in Q2 2023, streamlining biologic therapy approvals for autoimmune conditions. New requirements include pretreatment lab panels and step therapy documentation. Average approval times decreased from 14 to 8 business days post-implementation.",
  "metadata": {
    "format": "policy_document"
  }
}